RE:At This Point, Telesta Management is Key
Steve; your general hypothesis has validity but your suggestion that Telesta entered into this as a Canadian backwater is a misnomer. I am certain that had a US Pharma partner had representation at the table a Yes vote would have followed, but to suggest that there is a complete abscence of higher level participation in the FDA dialogue is not entirely accurate either. We all agree that the Telesta representation fumbled the greased ball when lateralled to them, but Monique the VP is not the Apex contact point with the FDA. There may not be an Eli Lilly involved but there are some big interests with equally big dollars who intend to see this through.